Sign in
4

Changes in Ownership

ADMA BIOLOGICS, INC. Filed Acc 0001140361-24-039822

COO and SVP, Compliance sold 24,150 shares at $16.90 ($408,050)

  • COO and SVP, Compliance acquired 24,150 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kestenberg-Messina Kaitlin M. · COO and SVP, Compliance

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2024-08-30 Exercise or conversion : show line 1 in the form +8,125 $2.35 $19,094 457,213 D
2024-08-30 Exercise or conversion : show line 2 in the form +4,375 $2.59 $11,331 461,588 D
2024-08-30 Exercise or conversion : show line 3 in the form +6,650 $5.94 $39,501 468,238 D
2024-08-30 Exercise or conversion : show line 4 in the form +5,000 $4.72 $23,600 473,238 D
2024-08-30 Sale : show line 5 in the form −24,150 $16.90 $408,050 449,088 D
Open-market sales · 24,150 sh · avg $16.90 · $408,050

Table II: Derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-08-30 Exercise or conversion : show line 6 in the form Common Stock −8,125 $2.35 $19,094 3,750 D
2024-08-30 Exercise or conversion : show line 7 in the form Common Stock −4,375 $2.59 $11,331 0 D
2024-08-30 Exercise or conversion : show line 8 in the form Common Stock −6,650 $5.94 $39,501 0 D
2024-08-30 Exercise or conversion : show line 9 in the form Common Stock −5,000 $4.72 $23,600 0 D
Loading xslF345X05/form4.xml…